Management of hyperstimulation syndrome.
A case of hyperstimulation syndrome secondary to Pergonal therapy is presented. Successful management was based principally on severe sodium and fluid restriction without the use of volume expanders. The rationale for this therapeutic approach is presented and discussed. Although this iatrogenic disease should be virtually eliminated with the monitoring of daily urinary estrogens, severe hyperstimulation may still occur as a result of laboratory error.
D000328:Adult; D001002:Anuria / Q000628:therapy*; D001201:Ascites / Q000139:chemically induced / Q000628:therapy; D002411:Cation Exchange Resins / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000009:adverse effects / Q000627:therapeutic use; D004039:Diet, Sodium-Restricted; D004967:Estrogens / Q000652:urine; D005260:Female; D006801:Humans; D006876:Hydrothorax / Q000139:chemically induced / Q000628:therapy*; D007049:Iatrogenic Disease; D007247:Infertility, Female / Q000188:drug therapy; D008596:Menotropins / Q000009:adverse effects* / Q000627:therapeutic use; D009846:Oliguria / Q000139:chemically induced / Q000628:therapy*; D010048:Ovarian Cysts / Q000139:chemically induced; D010049:Ovarian Diseases / Q000139:chemically induced* / Q000628:therapy; D011247:Pregnancy; D013268:Stimulation, Chemical; D013577:Syndrome; D014868:Water Deprivation
D002411:Cation Exchange Resins; D006063:Chorionic Gonadotropin; D004967:Estrogens; D008596:Menotropins